Biocon Biologics
Vinay Pandey has a strong background in biotechnology and project management, with a focus on process characterization and validation for bio similar Mabs targeted for regulated markets. With experience in various research associate and managerial roles, Vinay has a deep understanding of DoE and QbD principles. Vinay holds a Master's degree in Biotechnology and an MBA in Project Management, along with a P.G. Diploma in Patents Law.
This person is not in the org chart
Biocon Biologics
8 followers
Biocon Biologics Limited, a subsidiary of Biocon Limited, is a fully integrated global biosimilars organization. It is leveraging cutting-edge science, innovative tech platforms and advanced research & development capabilities to lower treatment costs while improving healthcare outcomes. It has a strong research pipeline of biosimilar molecules across diabetes, oncology, immunology, and other non-communicable diseases. Six molecules from Biocon Biologics’ portfolio have been taken from lab to market in developed markets like United States, EU, Australia, Canada and Japan. With a team of ~ 4,800 people, Biocon Biologics is committed to transforming healthcare and transforming lives by enabling affordable access to millions of patients’ worldwide. Follow-us on Twitter: @BioconBiologics